Clinical trials recruiting for Clear Cell Renal Cell Carcinoma (ccRCC)
5
Recruiting trials
31
US states with sites
13
Countries
0%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Cemiplimab | 2 |
| Adagrasib | 1 |
| Cabozantinib | 1 |
| DDI Probe Cocktail | 1 |
| Darlifarnib | 1 |
| Docetaxel | 1 |
| Ipilimumab | 1 |
| Nivolumab | 1 |
| Nivolumab + Relatlimab | 1 |
| Prednisone | 1 |
| REGN10597 | 1 |
| REGN15505 | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 5 |
| Texas | 5 |
| Arizona | 4 |
| Michigan | 4 |
| Pennsylvania | 4 |
| Colorado | 3 |
| Connecticut | 3 |
| Florida | 3 |
| Illinois | 3 |
| Massachusetts | 3 |
| Minnesota | 3 |
| New York | 3 |
Top cities
Houston, Texas 4Boston, Massachusetts 3Detroit, Michigan 3Jacksonville, Florida 3Phoenix, Arizona 3Pittsburgh, Pennsylvania 3Rochester, Minnesota 3Tucson, Arizona 3Celebration, Florida 2Charlottesville, Virginia 2
Self-screener
Recruiting trials
- A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
- A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
- KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma
- Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Related conditions
Trials recruiting for Clear Cell Renal Cell Carcinoma (ccRCC) often also study these conditions. Each links to its own recruiting-trial list.
Prostate cancer 1234Metastatic Castration-Resistant Prostate Cancer (mCRPC) 18Non-small cell lung cancer 507Lung cancer 2180Colorectal cancer 50Colorectal cancer 1359Urothelial Carcinoma (UC) 5Renal Cell Carcinoma (RCC) 10Renal Cell Carcinoma (Kidney Cancer) 6Pancreatic Ductal Adenocarcinoma (PDAC) 32
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Clear Cell Renal Cell Carcinoma (ccRCC) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.